CytomX’s Collaboration and Licensing Agreement With Regeneron Pharmaceuticals

Laura Testa North America Legal Chronicle
Tagged:

Latham & Watkins LLP represented CytomX in the transaction.Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and CytomX Therapeutics, Inc. (NASDAQ: CTMX) have announced a collaboration and licensing agreement…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here